CASI Trademark

Trademark Overview


On Wednesday, April 25, 2018, a trademark application was filed for CASI with the United States Patent and Trademark Office. The USPTO has given the CASI trademark a serial number of 87892837. The federal status of this trademark filing is REGISTERED as of Tuesday, May 14, 2019. This trademark is owned by CASI PHARMACEUTICALS, INC.. The CASI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; development of pharmaceutical preparations and medicines; provision of scientific information via Internet portals in the field of medical research and biotechnology; Product development research and product development in the field of pharmaceutical, biological and biotechnological products; medical research and product development services in the field of treatments for cancer, cardiovascular, metabolic, inflammatory, nervous system, anti-infective, and dermatological conditions; pharmaceutical research and development of human therapeutics using gene editing; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuti...
casi

General Information


Serial Number87892837
Word MarkCASI
Filing DateWednesday, April 25, 2018
Status700 - REGISTERED
Status DateTuesday, May 14, 2019
Registration Number5748674
Registration DateTuesday, May 14, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements


Translation of Words in MarkThe English translation of the word "CASI" in the mark is "ALMOST".
Goods and ServicesPharmaceutical research and development; development of pharmaceutical preparations and medicines; provision of scientific information via Internet portals in the field of medical research and biotechnology; Product development research and product development in the field of pharmaceutical, biological and biotechnological products; medical research and product development services in the field of treatments for cancer, cardiovascular, metabolic, inflammatory, nervous system, anti-infective, and dermatological conditions; pharmaceutical research and development of human therapeutics using gene editing; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Biochemical research and development; Biological research; Biomedical research services; Clinical research in the field of cancer; Conducting clinical trials for others in the field of cancer; Conducting early evaluations in the field of new pharmaceuticals; Genotyping services for research or analysis purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research; Scientific research and development; Stem cell research; Technical research in the field of pharmaceutical studies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 4, 2018
Primary Code042
First Use Anywhere DateMonday, June 16, 2014
First Use In Commerce DateMonday, June 16, 2014

Trademark Owner History


Party NameCASI PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameCASI PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameCASI PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Wednesday, January 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 28, 2018NEW APPLICATION ENTERED
Tuesday, May 1, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, May 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, May 6, 2018ASSIGNED TO LIE
Wednesday, May 9, 2018PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, August 16, 2018ASSIGNED TO EXAMINER
Thursday, August 16, 2018NON-FINAL ACTION WRITTEN
Thursday, August 16, 2018NON-FINAL ACTION E-MAILED
Thursday, August 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, May 14, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER